First in Human Study of TLC-ART 101 (ACTU 2001)

Clinical trial NCT05850728 · COMPLETED

Trial details

NCT number: NCT05850728
Sponsor: University of Washington
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus Treatment Antiretroviral Therapy

Start date: 2023-04-01
Primary completion: 2024-06-28
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.